Sign in
Taking peoplePhase 3

Weaning Approaches for Vasopressin in Sepsis

Key facts

Who runs it
Hospital Nossa Senhora da Conceicao
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
82 people, planned
Started
1 Oct 2025
Expected to end
1 Oct 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Titrated weaning of vasopressin.
  • Abrupt weaning of vasopressin.
Record updated
2 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Age over 18 years
  • Admitted to the Intensive Care Unit
  • Patients with vasopressor dependent sepsis
  • Receiving combined norepinephrine and vasopressin therapy

Who cannot take part

  • Withdrawal/reduction of vasopressin related to a plan of treatment limitation or palliative care
  • Withdrawal/reduction of vasopressin associated with the initiation of adrenaline or any other vasopressor

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Septic shock

This trial is currently available in Brazil.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this study, we aim to evaluate the incidence of hypotension during vasopressin weaning by comparing two methods - titrated reduction versus abrupt withdrawal - through the conduct of a randomized clinical trial.

The 2 groups in the trial

  • Titrated groupTreatment being tested

    The titrated group will follow the vasopressin weaning protocol used in the DOVSS study (reduction of 0.01 U/min per hour).

    Treatment: Titrated weaning of vasopressin.

  • Abrupt groupExisting treatment, for comparison

    The abrupt group will discontinue the vasopressin infusion at the time of randomization, without dose titration.

    Treatment: Abrupt weaning of vasopressin.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Weaning Approaches for Vasopressin in Sepsis - a Randomized Controlled Trial of Titrated Versus Abrupt Discontinuation During Stabilization of Septic Shock - WAVES Trial
Criteria questions
Built from NCT07067866, who can take part
Record updated
2 January 2026